Biotech / PharmaGreater Boston

Parabilis Medicines

Biotech / Pharma , MA

Peptide therapeutics (Helicon stapled-peptide platform, from Gregory Verdine's Harvard lab). Founded 2015 as Fog Pharmaceuticals; rebranded Parabilis Medicines. Undruggable intracellular targets; cancer. IPO closed 2026-06-11.

Founded

Region

Greater Boston

Investors

People

Gregory Verdine

About Greater Boston

Boston's venture ecosystem runs on its universities — MIT and Harvard across the Charles River from each other, Boston University down the bank in the Fenway/Kenmore area, all fueling a dense pipeline of biotech and deep tech spinouts. Kendall Square functions as a walkable biotech campus in its own right, but it's really one node in a wider river-and-campus geography — the region's life sciences density comes from several schools feeding the same square mile, not just one.

Region Stats

Total firms 327

VC / investors 53

Companies 255

Schools 19

Known For

Life Sciences

Deep Tech

Venture Capital